APA
Click to copy
Park, S.-Y., Pekas, E. J., Headid, R. J., Son, W.-M., Wooden, T. S. K., Song, J., … Pipinos, I. (2020). Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in peripheral artery disease patients. American Journal of Physiology. Heart and Circulatory Physiology.
Chicago/Turabian
Click to copy
Park, Song-Young, Elizabeth J Pekas, Ronald J Headid, Won-Mok Son, TeSean K. Wooden, Jiwon Song, G. Layec, S. Yadav, P. Mishra, and I. Pipinos. “Acute Mitochondrial Antioxidant Intake Improves Endothelial Function, Antioxidant Enzyme Activity, and Exercise Tolerance in Peripheral Artery Disease Patients.” American Journal of Physiology. Heart and Circulatory Physiology (2020).
MLA
Click to copy
Park, Song-Young, et al. “Acute Mitochondrial Antioxidant Intake Improves Endothelial Function, Antioxidant Enzyme Activity, and Exercise Tolerance in Peripheral Artery Disease Patients.” American Journal of Physiology. Heart and Circulatory Physiology, 2020.
BibTeX Click to copy
@article{song-young2020a,
title = {Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in peripheral artery disease patients.},
year = {2020},
journal = {American Journal of Physiology. Heart and Circulatory Physiology},
author = {Park, Song-Young and Pekas, Elizabeth J and Headid, Ronald J and Son, Won-Mok and Wooden, TeSean K. and Song, Jiwon and Layec, G. and Yadav, S. and Mishra, P. and Pipinos, I.}
}
Peripheral artery disease (PAD) is a manifestation of atherosclerosis in the leg arteries, which causes claudication. This may be in part due to vascular mitochondrial dysfunction and excessive reactive oxygen species (ROS) production. A mitochondrial-targeted antioxidant (MitoQ) has been shown to improve vascular mitochondrial function which, in turn, led to improved vascular function in older adults and animal models. However, the roles of vascular mitochondria in vascular function including endothelial function and arterial stiffness in patients with PAD are unknown, therefore, by utilizing acute MitoQ intake, this study examined the roles of vascular mitochondria in endothelial function, arterial stiffness, exercise tolerance, and skeletal muscle function in patients with PAD. 11 patients with PAD received either MitoQ or placebo in a randomized crossover design. At each visit, blood samples, brachial and popliteal artery flow-mediated dilation (FMD), peripheral and central pulse-wave velocity (PWV), blood pressure (BP), maximal walking capacity, time to claudication (COT), and oxygen utility capacity were measured pre-and-post MitoQ and placebo. There were significant group by time interactions (p<0.05) for brachial and popliteal FMD which both increased (Δ2.6% and Δ3.3%, respectively), and increases superoxide dismutase (Δ0.03 U/mL), maximal walking time (Δ73.8 s), maximal walking distance (Δ49.3 m) and COT (Δ44.2 s). There were no changes in resting heart rate, BP, malondialdehyde, total antioxidant capacity, PWV, or oxygen utility capacity (p>0.05). MitoQ intake may be an effective strategy for targeting the vascular mitochondrial environment, which may be useful for restoring endothelial function, leg pain, and walking time in patients with PAD.
